Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease
Top Cited Papers
- 25 August 2009
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 106 (34) , 14670-14675
- https://doi.org/10.1073/pnas.0903563106
Abstract
Mitochondrial dysfunction has been proposed to play a pivotal role in neurodegenerative diseases, including Alzheimer's disease (AD). To address whether mitochondrial dysfunction precedes the development of AD pathology, we conducted mitochondrial functional analyses in female triple transgenic Alzheimer's mice (3xTg-AD) and age-matched nontransgenic (nonTg). Mitochondrial dysfunction in the 3xTg-AD brain was evidenced by decreased mitochondrial respiration and decreased pyruvate dehydrogenase (PDH) protein level and activity as early as 3 months of age. 3xTg-AD mice also exhibited increased oxidative stress as manifested by increased hydrogen peroxide production and lipid peroxidation. Mitochondrial amyloid beta (Aβ) level in the 3xTg-AD mice was significantly increased at 9 months and temporally correlated with increased level of Aβ binding to alcohol dehydrogenase (ABAD). Embryonic neurons derived from 3xTg-AD mouse hippocampus exhibited significantly decreased mitochondrial respiration and increased glycolysis. Results of these analyses indicate that compromised mitochondrial function is evident in embryonic hippocampal neurons, continues unabated in females throughout the reproductive period, and is exacerbated during reproductive senescence. In nontransgenic control mice, oxidative stress was coincident with reproductive senescence and accompanied by a significant decline in mitochondrial function. Reproductive senescence in the 3xTg-AD mouse brain markedly exacerbated mitochondrial dysfunction. Collectively, the data indicate significant mitochondrial dysfunction occurs early in AD pathogenesis in a female AD mouse model. Mitochondrial dysfunction provides a plausible mechanistic rationale for the hypometabolism in brain that precedes AD diagnosis and suggests therapeutic targets for prevention of AD.Keywords
This publication has 40 references indexed in Scilit:
- Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer diseaseNeurology, 2009
- Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normalNeurobiology of Aging, 2008
- Mitochondria as ChiGenetics, 2008
- Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neuronsProceedings of the National Academy of Sciences, 2008
- Progesterone and Estrogen Regulate Oxidative Metabolism in Brain MitochondriaEndocrinology, 2008
- Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's diseaseTrends in Molecular Medicine, 2008
- Progesterone and Estrogen Regulate Alzheimer-Like Neuropathology in Female 3xTg-AD MiceJournal of Neuroscience, 2007
- Oxidative Stress and Transcriptional Regulation in Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 2007
- Energy Inhibition Elevates β-Secretase Levels and Activity and Is Potentially Amyloidogenic in APP Transgenic Mice: Possible Early Events in Alzheimer's Disease PathogenesisJournal of Neuroscience, 2005
- Mitochondria dysfunction of Alzheimer's disease cybrids enhances Aβ toxicityJournal of Neurochemistry, 2004